文献速递头颈外科

头颈部默克尔细胞癌:28年单中心诊疗经验

Merkel Cell Carcinoma: A 28-Year Experience.
PubMed 文献 · Otolaryngol Head Neck Surg · 2020-03-31

该研究回顾性分析了1990年5月至2018年12月单中心60例头颈部默克尔细胞癌患者的诊疗与复发结局,发现影像学对隐匿病变的敏感性和特异性中等,前哨淋巴结活检阴性率高,1、2、5年无复发生存率分别为50%、45%、42%,传统预测因素可能无法识别复发风险。

要点

  • 影像学对隐匿病变的识别能力中等,不能替代前哨淋巴结活检。
  • 前哨淋巴结活检阴性率较高,传统预测因素可能无法识别复发风险。
  • 接受颈部放疗或颈清扫的患者与未接受颈部治疗者复发率相似。

核心结论

  • 本研究报告的复发率和前哨淋巴结活检阴性率高于其他研究。
  • 影像学可能不是前哨淋巴结活检的替代方法,其识别隐匿病变的能力为中等。
  • 传统预测因素包括前哨淋巴结活检和颈部淋巴结病理,可能无法识别头颈部默克尔细胞癌的复发风险患者。
  • 接受颈部放疗或颈清扫治疗的患者与未接受颈部治疗者的复发率相似。

研究设计与样本

  • 回顾性综述,纳入1990年5月至2018年12月单中心60例头颈部默克尔细胞癌患者。

主要发现

  • 60例患者中男性占67%(40/60),平均年龄73.3岁。
  • 42%(25/60)的患者接受颈清扫,12%(7/60)接受前哨淋巴结活检。
  • 大多数患者仅接受手术治疗(29/60),21/60接受手术加辅助治疗,10/60接受放疗伴或不伴化疗。
  • 1年、2年和5年无复发生存率分别为50%、45%和42%。

临床怎么用

  • 影像学检查不能替代前哨淋巴结活检用于评估隐匿病变。
  • 需注意传统预测因素可能不足以识别复发高风险患者。
  • 颈部放疗或颈清扫与未接受颈部治疗者的复发率相似,治疗选择需个体化。

局限性

  • 回顾性单中心研究,样本量有限(60例)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate the management and recurrence outcomes of head and neck Merkel cell carcinoma (HN-MCC) at a single institution. STUDY DESIGN: A retrospective review of outcomes in patients with HN-MCC. SETTING: A tertiary center from May 1990 to December 2018. SUBJECTS AND METHODS: Electronic medical records of patients with HN-MCC were reviewed. RESULTS: Sixty cases were included, with 67% (40 of 60) males and a mean age of 73.3 years. Imaging had a moderate sensitivity and specificity for detection of occult disease when compared with histopathologic analysis. Forty-two percent (25 of 60) of patients underwent neck dissection, and 12% (7 of 60) had a sentinel lymph node biopsy (SLNB). There was a high rate of negative SLNB findings. The majority of patients were treated with surgery alone (29 of 60), followed by a cohort (21 of 60) treated with surgery plus adjuvant treatment, and 10 of 60 patients were treated with radiation therapy with or without chemotherapy. Recurrence-free survival was 50%, 45%, and 42% at 1, 2, and 5 years. CONCLUSIONS: We report higher recurrence rates and higher negative SLNB result rates than other studies. Our results affirm that imaging may not be a substitute for SLNB and that it had an intermediate ability to identify the occult disease. Traditional predictors, including SLNB and cervical node pathology, may not identify patients at risk for recurrence in HN-MCC. We report similar recurrence rates in patients who had treatment of the cervical nodes by radiation therapy or neck dissection as compared with those who did not receive neck treatment.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Kwan K, Ghazizadeh S, Moon AS, et al. Merkel Cell Carcinoma: A 28-Year Experience. Otolaryngol Head Neck Surg. 2020. PMID: 32228136. doi:10.1177/0194599820913622

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。